Description
High-quality serological antibody testing is not only key in the overall surveillance of the COVID-19 pandemic, but also serves as a crucial tool in the assessment of the vaccine effectiveness. The accelerated process of the vaccine development strongly relies on the availability of serological tests that can help assess the extent of the induced production of antibodies to the SARS-CoV-2 virus.
Our test kit rivals/competes with Roche’s PCR Elecsys’ Anti-Sars-CoV-2Assay, without the need of any equipment or lab to achieve results.
Most serological tests only detect IgG and/or IgM antibodies, while the Total Antibody Test with the patented “Vertical Flow” system detects all human immunoglobulins, including IgG, IgM and IgA – an advantage that no other rapid test on the market has.
